Archives of Pediatric Infectious Diseases

Published by: Kowsar
Crossmark
Uncorrected Proof scheduled for 7 (3)

Assessment of Routine Measles Vaccine Effectiveness Among Children Referring to Tertiary Fever Hospital in Egypt

John Rene Labib 1 , * , Eman Hany Elsebaie 2 , Shaimaa A.M. Abd El Fatah 2 , Silvia Farouk Shalaby 2 and Engy El Khateeb 3
Authors Information
1 Pediatrics Department, Faculty of Medicine, Cairo University, Cairo, Egypt
2 Public Health Department, Faculty of Medicine, Cairo University, Cairo, Egypt
3 Clinical Pathology Department, Faculty of Medicine, Cairo University, Cairo, Egypt
Article information
  • Archives of Pediatric Infectious Diseases: In Press (In Press); e90407
  • Published Online: July 9, 2019
  • Article Type: Research Article
  • Received: February 6, 2019
  • Revised: May 30, 2019
  • Accepted: June 13, 2019
  • DOI: 10.5812/pedinfect.90407

To Cite: Labib J R, Elsebaie E H, Abd El Fatah S A, Shalaby S F , El Khateeb E . Assessment of Routine Measles Vaccine Effectiveness Among Children Referring to Tertiary Fever Hospital in Egypt, Arch Pediatr Infect Dis. Online ahead of Print ; In Press(In Press):e90407. doi: 10.5812/pedinfect.90407.

Abstract
Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. World Health Organization. Progress in reducing global measles deaths: 1999-2002. The Weekly Epidemiological Record; 2004.
  • 2. Park K. Park's textbook of preventive and social medicine. 19th ed. India: Bhanot Publishers; 2007.
  • 3. Mishra A, Mishra S, Lahariya C, Jain P, Bhadoriya RS, Shrivastav D, et al. Practical observations from an epidemiological investigation of a measles outbreak in a district of India. Indian J Community Med. 2009;34(2):117-21. doi: 10.4103/0970-0218.51234. [PubMed: 19966957]. [PubMed Central: PMC2781117].
  • 4. Bharti B, Bharti S. Measles in a hilly hamlet of northern India. Indian J Pediatr. 2002;69(12):1033-5. [PubMed: 12557954].
  • 5. Sharma MK, Bhatia V, Swami HM. Outbreak of measles amongst vaccinated children in a slum of Chandigarh. Indian J Med Sci. 2004;58(2):47-53. [PubMed: 14993716].
  • 6. Bhatia V, Swami HM, Rai SK, Gulati S, Verma A, Parashar A, et al. Immunization status in children. Indian J Pediatr. 2004;71(4):313-5. doi: 10.1007/bf02724097.
  • 7. Puri A, Gupta VK, Chakravarti A, Mehra M. Measles vaccine efficacy evaluated by case reference technique. Indian Pediatr. 2002;39(6):556-60. [PubMed: 12084949].
  • 8. Nelesone T, Durrheim DN, Speare R, Kiedrzynski T, Melrose WD. Short communication: Strengthening sub-national communicable disease surveillance in a remote Pacific Island country by adapting a successful African outbreak surveillance model. Trop Med Int Health. 2006;11(1):17-21. doi: 10.1111/j.1365-3156.2005.01534.x. [PubMed: 16398751].
  • 9. El Sayed N, Kandeel N, Barakat I, Moussa I, Alexander JJ, Naouri B, et al. Progress toward measles and rubella elimination in Egypt. J Infect Dis. 2011;204 Suppl 1:S318-24. doi: 10.1093/infdis/jir123. [PubMed: 21666180].
  • 10. Ahmed H. Updates in the situation of the Eastern Mediterranean region. 13th annual meeting measles and Rubella initiatives American Red Cross-national headquarters. 2014 September 9-10; Washington DC. Vaccine preventable diseases and immunization WHO/ EMRO; 2014.
  • 11. World Health Organization. Measles-Rubella campaign, phase one, 2 May-30 November 2008, Egypt. 2018, [cited 2018 November 24]. Available from: http://jid.oxfordjournals.org/content/204/suppl_1/S318.full.
  • 12. World Health Organization. Measles-cases. 2017, [cited 2018 December 18]. Available from: https://knoema.com/atlas/Egypt/topics/Health/CommunicableDiseases/Measles-cases2017.
  • 13. World Health Organization. Global Vaccine Action Plan (GVAP) Secretariat report 2015 measles. 2015, [cited 2018 November 29]. Available from: http://www.who.int/immunization/sage/meetings/2015/october/8_GVAP_Secretariat_report_2015_Measles.pdf.
  • 14. National Institute of Communicable Diseases. Manual for investigation and control of outbreak of measles. Govt. of India, Delhi's: Director General of Health Services; 2006, [cited 2018 December 14]. Available from: http://www.ncdc.gov.in/.
  • 15. Thompson A, Temple N. Ethics, medical research, and medicine: Commercialism versus environmentalism and social justice. Springer Science & Business Media; 2001. doi: 10.1007/978-94-010-0794-8.
  • 16. World Health Organization. Surveillance guidelines for measles, Rubella and Congenital Rubella Syndrome in the WHO European region. 2009, [cited 2018 November 25]. Available from: www.who.int/immunization/documents/measles_rubella_eur_08_5082738/en/.
  • 17. Musa S, Topalovic B, Catic S, Smajlagic Z. Assessment of vaccine effectiveness during measles outbreak in the Federation of Bosnia and Herzegovina, 2014-2015. Cent Eur J Public Health. 2018;26(2):79-82. doi: 10.21101/cejph.a4754. [PubMed: 30102493].
  • 18. Pillsbury A, Quinn H. An assessment of measles vaccine effectiveness, Australia, 2006-2012. Western Pac Surveill Response J. 2015;6(3):43-50. doi: 10.5365/WPSAR.2015.6.2.007. [PubMed: 26668766]. [PubMed Central: PMC4675157].
  • 19. Aylward RB, Clements J, Olive JM. The impact of immunization control activities on measles outbreaks in middle and low income countries. Int J Epidemiol. 1997;26(3):662-9. doi: 10.1093/ije/26.3.662. [PubMed: 9222794].
  • 20. Yermalovich MA, Hubschen JM, Semeiko GV, Samoilovich EO, Muller CP. Human parvovirus B19 surveillance in patients with rash and fever from Belarus. J Med Virol. 2012;84(6):973-8. doi: 10.1002/jmv.23294. [PubMed: 22499021].
  • 21. Crawley J, Sismanidis C, Goodman T, Milligan P; W. H. O. Advisory Committee on serological responses to vaccines used in the Expanded Programme on Immunization in infants receiving Intermittent Preventive Treatment for malaria. Effect of intermittent preventive treatment for malaria during infancy on serological responses to measles and other vaccines used in the Expanded Programme on Immunization: Results from five randomised controlled trials. Lancet. 2012;380(9846):1001-10. doi: 10.1016/S0140-6736(12)60775-2. [PubMed: 22850358].
  • 22. Magalhaes Ide M, Martins RV, Vianna RO, Moyses N, Afonso LA, Oliveira SA, et al. Detection of human herpesvirus 7 infection in young children presenting with exanthema subitum. Mem Inst Oswaldo Cruz. 2011;106(3):371-3. doi: 10.1590/s0074-02762011000300020. [PubMed: 21655829].
  • 23. Dossetor J, Whittle HC, Greenwood BM. Persistent measles infection in malnourished children. Br Med J. 1977;1(6077):1633-5. doi: 10.1136/bmj.1.6077.1633. [PubMed: 871699]. [PubMed Central: PMC1607735].
  • 24. Moss WJ. Measles control and the prospect of eradication. Curr Top Microbiol Immunol. 2009;330:173-89. [PubMed: 19203110].
  • 25. Ogundiji OT, Okonko IO, Adu FD. Determination of measles hemagglutination inhibiting antibody levels among school children in Ibadan, Nigeria. J Immunoassay Immunochem. 2013;34(2):208-17. doi: 10.1080/15321819.2012.699496. [PubMed: 23537304].
  • 26. Pomerai KW, Mudyiradima RF, Gombe NT. Measles outbreak investigation in Zaka, Masvingo province, Zimbabwe, 2010. BMC Res Notes. 2012;5(1):687. doi: 10.1186/1756-0500-5-687. [PubMed: 23253554]. [PubMed Central: PMC3541261].
  • 27. Jasem J, Marof K, Nawar A, Monirul Islam KM. Epidemiological analysis of measles and evaluation of measles surveillance system performance in Iraq, 2005-2010. Int J Infect Dis. 2012;16(3):e166-71. doi: 10.1016/j.ijid.2011.11.002. [PubMed: 22192582].
  • 28. Doshi RH, Mukadi P, Shidi C, Mulumba A, Hoff NA, Gerber S, et al. Field evaluation of measles vaccine effectiveness among children in the Democratic Republic of Congo. Vaccine. 2015;33(29):3407-14. doi: 10.1016/j.vaccine.2015.04.067. [PubMed: 25937449].
  • 29. Siennicka J, Stefanoff P, Rogalska J, Trzcinska A. Etiology of measles suspect cases reported in 2006-2007 in Poland. Przegl Epidemiol. 2011;65(1):39-44. [PubMed: 21735834].
  • 30. Onoja AB, Adeniji AJ, Faneye A. Measles complications in a Nigerian hospital setting. Clin Rev Opin. 2013;5:18-23. doi: 10.5897/CRO12.008.
  • 31. Onoja AB, Adeniji AJ. Kinetics of measles antibody by hemagglutination inhibition assay in children in south-west and north-central Nigeria. Int J Infect Dis. 2013;17(7):e552-5. doi: 10.1016/j.ijid.2013.02.001. [PubMed: 23510540].
  • 32. Portnoy A, Jit M, Helleringer S, Verguet S. Impact of measles supplementary immunization activities on reaching children missed by routine programs. Vaccine. 2018;36(1):170-8. doi: 10.1016/j.vaccine.2017.10.080. [PubMed: 29174680]. [PubMed Central: PMC5949217].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments